# US 2022/0037016 A1 · Insulin Management

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0037016 A1
- Document ID: US20220037016A1
- Status: Published application
- Kind: A1
- Application number: 17/305,661
- Filed: 2021-07-12
- Published: 2022-02-03
- Earliest claimed: 2014-01-31
- Assignees: Aseko, Inc.
- Applicants: Aseko, Inc.
- Inventors: Robert C Booth; Harry Hebblewhite
- Web page: https://patentgrep.com/patent/US20220037016A1

## CPC

- G16H 40/67: for remote operation
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/14: Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- G16H 20/17: delivered via infusion or injection
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 80/00: ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61M 2005/14208: {with a programmable infusion control system, characterised by the infusion program}
- A61M 2005/14296: {Pharmacokinetic models}
- A61M 2005/1726: {the body parameters being measured at, or proximate to, the infusion site}
- A61M 2205/18: with alarm
- A61M 2205/3327: Measuring
- A61M 2205/35: Communication
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/50: with microprocessors or computers
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/507: Head Mounted Displays [HMD]
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/581: by audible feedback
- A61M 2230/201: Glucose concentration
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of administering insulin includes receiving glucose measurements of a patient at a data processing device from a continuous glucose monitoring system. The glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.

## Claims

### Claim 1

A computer-implemented method when executed on data processing hardware causes the data processing hardware to perform operations comprising:
obtaining a glucose measurement of a patient from a continuous glucose monitoring system in communication with the data processing hardware;
determining a glucose type of the received glucose measurement; and
when the determined glucose type comprises one of a pre-lunch glucose measurement or a pre-dinner glucose measurement:
obtaining a Carbohydrate-to-Insulin Ratio for the patient;
determining an adjustment factor based on the received glucose measurement;
adjusting the Carbohydrate-to-Insulin Ratio for the patient by dividing the Carbohydrate-to-Insulin Ratio by the adjustment factor;
determining a recommended meal bolus for the determined glucose type based on the adjusted Carbohydrate-to-Insulin Ratio; and
displaying, on a display in communication with the data processing hardware, the recommended meal bolus.

### Claim 2 (depends on 1)

The method of claim 1, wherein the operations further comprise, when the determined glucose type comprises one of a pre-lunch glucose measurement or a pre-dinner glucose measurement:
transmitting the recommended meal bolus to an administration device in communication with the data processing hardware, the administration device comprising:
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the recommended meal bolus.

### Claim 3 (depends on 1)

The method of claim 1, wherein the operations further comprise determining a pre-meal correction bolus by calculating:
CB=(BG−B GTarget)/CF
wherein CB is the pre-meal correction bolus, BG is the received glucose measurement, BGTarget is a target glucose value of a patient, and CF is a correction factor.

### Claim 4 (depends on 1)

The method of claim 1, wherein determining the adjustment factor comprises:
determining whether the glucose value is within one of a plurality of target ranges of values; and
when the glucose measurement is within one of the plurality of target ranges of values, setting the adjustment factor to a target adjustment factor associated with the corresponding target range of values that includes the glucose measurement.

### Claim 5 (depends on 4)

The method of claim 4, wherein the plurality of target ranges of values comprises:
a first target range of values including glucose values less than a first configurable constant;
a second target range of values including glucose values greater than or equal to the first configurable constant and less than a low target glucose value of a target glucose range for the patient;
a third target range of values including glucose values greater than or equal to the low target glucose value and less than a high target glucose value of the target glucose range;
a fourth target range of values including glucose values greater than or equal to the high target glucose value and less than a second configurable constant;
a fifth target range of values including glucose values greater than or equal to the second configurable constant and less than a third configurable constant; and
a sixth target range of values including glucose values greater than or equal to the third configurable constant.

### Claim 6 (depends on 1)

The method of claim 1, wherein the glucose type is associated with a glucose time associated with a time of measuring the glucose measurement, the glucose type including one of a midsleep glucose measurement, a pre-breakfast glucose measurement, the pre-lunch glucose measurement, the pre-dinner glucose measurement, and a bedtime glucose measurement, wherein the midsleep, pre-breakfast, pre-lunch, pre-dinner, and bedtime glucose measurements are scheduled in a daily repetitive rotational order.

### Claim 7 (depends on 1)

The method of claim 1, wherein determining the recommended meal bolus comprises:
receiving a number of carbohydrates to be consumed by the patient for a meal associated with the determined glucose type; and
dividing the received number of carbohydrates by the adjusted Carbohydrate-to-Insulin Ratio.

### Claim 8 (depends on 1)

The method of claim 1, wherein obtaining the Carbohydrate-to-Insulin Ratio for the patient comprises obtaining a previous Carbohydrate-to-Insulin Ratio for an immediately previous meal consumed by the patient.

### Claim 9 (depends on 8)

The method of claim 8, wherein adjusting the Carbohydrate-to-Insulin Ratio for the patient comprises, when the determined glucose type comprises the pre-lunch glucose measurement:
obtaining the previous Carbohydrate-to-Insulin Ratio for breakfast; and
determining a recommended Carbohydrate-to-Insulin Ratio for lunch by dividing the previous Carbohydrate-to-Insulin Ratio for breakfast by the adjustment factor.

### Claim 10 (depends on 8)

The method of claim 8, wherein adjusting the Carbohydrate-to-Insulin Ratio for the patient comprises, when the determined glucose type comprises the pre-dinner glucose measurement:
obtaining the previous Carbohydrate-to-Insulin Ratio for lunch; and
determining a recommended Carbohydrate-to-Insulin Ratio for dinner by dividing the previous Carbohydrate-to-Insulin Ratio for lunch by the adjustment factor.

### Claim 11 (depends on 1)

The method of claim 1, wherein the operations further comprise, when the determined glucose type comprises a pre-breakfast glucose measurement:
obtaining a previous Carbohydrate-to-Insulin Ratio for dinner;
obtaining a previous bedtime glucose measurement;
determining a bedtime adjustment factor based on the previous bedtime glucose measurement; and
determining a recommended Carbohydrate-to-Insulin Ratio for breakfast by dividing the previous Carbohydrate-to-Insulin Ratio for dinner by the bedtime adjustment factor.

### Claim 12 (depends on 11)

The method of claim 11, wherein the operations further comprise:
receiving a number of carbohydrates to be consumed by the patient for breakfast; and
determining a recommended breakfast bolus by dividing the received number of carbohydrates by the recommended Carbohydrate-to-Insulin Ratio for breakfast.

### Claim 13 (depends on 12)

The method of claim 12, wherein the operations further comprise:
transmitting the recommended breakfast bolus from the data processing device to an administration device in communication with the data processing hardware, the administration device comprising:
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the recommended breakfast bolus.

### Claim 14 (depends on 1)

The method of claim 1, wherein the operations further comprise, when the determined glucose type comprises a pre-breakfast glucose measurement:
selecting a governing glucose as a lesser one of a previous midsleep glucose measurement or the pre-breakfast glucose measurement;
determining a basal adjustment factor for adjusting a current day's recommended basal dose based on the selected governing glucose measurement;
obtaining a previous day's bed time recommended basal dose; and
determining the current day's recommended basal dose by multiplying the adjustment factor times the previous day's bed time recommended basal dose, the current day's recommended basal dose corresponding to an insulin dose of long-acting insulin to be administered to the patient at a configurable frequency of one, two, or three times per day.

### Claim 15

A system comprising:
a continuous glucose monitoring system; and
a dosing controller in communication with the continuous glucose monitoring system, the dosing controller including data processing hardware and memory hardware in communication with the data processing hardware, the dosing controller configured to perform operations comprising:
receiving a glucose measurement of a patient from the continuous glucose monitoring system;
determining a glucose type of the received glucose measurement; and
when the determined glucose type comprises one of a pre-lunch glucose measurement or a pre-dinner glucose measurement:
obtaining a Carbohydrate-to-Insulin Ratio for the patient;
determining an adjustment factor based on the received glucose measurement;
adjusting the Carbohydrate-to-Insulin Ratio for the patient by dividing the Carbohydrate-to-Insulin Ratio by the adjustment factor;
determining a recommended meal bolus for the determined glucose type based on the adjusted Carbohydrate-to-Insulin Ratio; and
displaying on a display, the recommended meal bolus.

### Claim 16 (depends on 15)

The system of claim 15, wherein the operations further comprise, when the determined glucose type comprises one of a pre-lunch glucose measurement or a pre-dinner glucose measurement:
transmitting the recommended meal bolus to an administration device in communication with the dosing controller, the administration device comprising:
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the recommended meal bolus.

### Claim 17 (depends on 15)

The system of claim 15, wherein the operations further comprise determining a pre-meal correction bolus by calculating:
CB=(BG−BGTarget)/CF
wherein CB is the pre-meal correction bolus, BG is the received glucose measurement, BGTarget is a target glucose value of a patient, and CF is a correction factor.

### Claim 18 (depends on 15)

The system of claim 15, wherein determining the adjustment factor comprises:
determining whether the glucose value is within one of a plurality of target ranges of values; and
when the glucose measurement is within one of the plurality of target ranges of values, setting the adjustment factor to a target adjustment factor associated with the corresponding target range of values that includes the glucose measurement.

### Claim 19 (depends on 18)

The system of claim 18, wherein the plurality of target ranges of values comprises:
a first target range of values including glucose values less than a first configurable constant;
a second target range of values including glucose values greater than or equal to the first configurable constant and less than a low target glucose value of a target glucose range for the patient;
a third target range of values including glucose values greater than or equal to the low target glucose value and less than a high target glucose value of the target glucose range;
a fourth target range of values including glucose values greater than or equal to the high target glucose value and less than a second configurable constant;
a fifth target range of values including glucose values greater than or equal to the second configurable constant and less than a third configurable constant; and
a sixth target range of values including glucose values greater than or equal to the third configurable constant.

### Claim 20 (depends on 15)

The system of claim 15, wherein the glucose type is associated with a glucose time associated with a time of measuring the glucose measurement, the glucose type including one of a midsleep glucose measurement, a pre-breakfast glucose measurement, the pre-lunch glucose measurement, the pre-dinner glucose measurement, and a bedtime glucose measurement, wherein the midsleep, pre-breakfast, pre-lunch, pre-dinner, and bedtime glucose measurements are scheduled in a daily repetitive rotational order.

### Claim 21 (depends on 15)

The system of claim 15, wherein determining the recommended meal bolus comprises:
receiving a number of carbohydrates to be consumed by the patient for a meal associated with the determined glucose type; and
dividing the received number of carbohydrates by the adjusted Carbohydrate-to-Insulin Ratio.

### Claim 22 (depends on 15)

The system of claim 15, wherein obtaining the Carbohydrate-to-Insulin Ratio for the patient comprises obtaining a previous Carbohydrate-to-Insulin Ratio for an immediately previous meal consumed by the patient.

### Claim 23 (depends on 22)

The system of claim 22, wherein adjusting the Carbohydrate-to-Insulin Ratio for the patient comprises, when the determined glucose type comprises the pre-lunch glucose measurement:
obtaining the previous Carbohydrate-to-Insulin Ratio for breakfast; and
determining a recommended Carbohydrate-to-Insulin Ratio for lunch by dividing the previous Carbohydrate-to-Insulin Ratio for breakfast by the adjustment factor.

### Claim 24 (depends on 22)

The system of claim 22, wherein adjusting the Carbohydrate-to-Insulin Ratio for the patient comprises, when the determined glucose type comprises the pre-dinner glucose measurement:
obtaining the previous Carbohydrate-to-Insulin Ratio for lunch; and
determining a recommended Carbohydrate-to-Insulin Ratio for dinner by dividing the previous Carbohydrate-to-Insulin Ratio for lunch by the adjustment factor.

### Claim 25 (depends on 15)

The system of claim 15, wherein the operations further comprise, when the determined glucose type comprises a pre-breakfast glucose measurement:
obtaining a previous Carbohydrate-to-Insulin Ratio for dinner;
obtaining a previous bedtime glucose measurement;
determining a bedtime adjustment factor based on the previous bedtime glucose measurement; and
determining a recommended Carbohydrate-to-Insulin Ratio for breakfast by dividing the previous Carbohydrate-to-Insulin Ratio for dinner by the bedtime adjustment factor.

### Claim 26 (depends on 25)

The system of claim 25, wherein the operations further comprise:
receiving a number of carbohydrates to be consumed by the patient for breakfast; and
determining a recommended breakfast bolus by dividing the received number of carbohydrates by the recommended Carbohydrate-to-Insulin Ratio for breakfast.

### Claim 27 (depends on 26)

The system of claim 26, wherein the operations further comprise:
transmitting the recommended breakfast bolus to an administration device in communication with the data processing hardware, the administration device comprising:
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the recommended breakfast bolus.

### Claim 28 (depends on 15)

The system of claim 15, wherein the operations further comprise, when the determined glucose type comprises a pre-breakfast glucose measurement:
selecting a governing glucose as a lesser one of a previous midsleep glucose measurement or the pre-breakfast glucose measurement;
determining basal adjustment factor for adjusting a current day's recommended basal dose based on the selected governing glucose measurement;
obtaining a previous day's bed time recommended basal dose; and
determining the current day's recommended basal dose by multiplying the basal adjustment factor times the previous day's bed time recommended basal dose, the current day's recommended basal dose corresponding to an insulin dose of long-acting insulin to be administered to the patient at a configurable frequency of one, two, or three times per day.
